Source: Health Products and Food Branch (CA) Revision Year: 2021
Adults and children 12 years of age and over: REACTINE (cetirizine hydrochloride) is indicated for the fast relief of nasal and non-nasal symptoms associated with seasonal and perennial allergic rhinitis (i.e. sneezing, rhinorrhea, postnasal discharge, nasal congestion/stuffiness, tearing and redness of the eyes, itchy nose/throat) and chronic idiopathic urticaria (e.g. pruritus and hives).
Pediatrics – Children 2-12 years of age: REACTINE is indicated for the relief of the symptoms associated with seasonal allergic rhinitis. REACTINE is also indicated for the fast and long-lasting relief of itching due to allergic skin reactions such as hives.
The nasal congestion/stuffiness and itchy nose/throat symptoms have not been adequately studied in the pediatric 2-12 years of age patient subset. The effectiveness of REACTINE in treating symptoms associated with perennial allergic rhinitis and chronic idiopathic urticaria has not been established in this age group.
The recommended initial dose of REACTINE (cetirizine hydrochloride) is 5 to 10 mg, depending on symptom severity, given as a single daily dose, with or without food. If sufficient response is not obtained with the nonprescription strengths of 5 or 10 mg, the dose may be increased and prescribed as necessary to the maximum recommended daily dose of 20 mg. The time of administration, with or without food, may be varied to suit individual patient needs.
In patients with moderate hepatic and/or renal impairment or adults 65 years and over, a starting dose of 5 mg/day is recommended.
REACTINE should not be administered to children under 2 years of age, unless advised by a physician.
Clinical studies to date support treatment for up to 6 months thus medical recommendation is advised for long-term use.
Specific dosing directions for various dosage forms of REACTINE are provided below:
Note: 20 mg film-coated tablets are only available under prescription; please consult your physician
Overdose has been reported with REACTINE (cetirizine hydrochloride). Symptoms observed after an overdose of cetirizine are mainly associated with CNS effects or with symptoms that could suggest an anticholinergic effect. Adverse events reported after an intake of at least 5 times the recommended daily dose are: confusion, diarrhea, dizziness, fatigue, headache, malaise, mydriasis, pruritus, restlessness, sedation, somnolence, stupor, tachycardia, hypertension, tremor, and urinary retention. Hyperactivity and severe lethargy have been seen in children. If an acute overdose occurs, evacuation of the stomach should be considered during the first few hours after this overdose. Treatment should be symptomatic and supportive taking into account any concomitantly ingested medications. There is no known specific antidote to REACTINE (cetirizine hydrochloride). REACTINE (cetirizine hydrochloride) is not effectively removed by dialysis, and dialysis will be ineffective unless a dialyzable agent has been concomitantly ingested. The minimal lethal oral dose in rodents is at least 590 times the maximum clinically studied dose.
For management of a suspected drug overdose, contact your regional Poison Control Centre.
Recommended storage: Store between 15°-30°C.
REACTINE Allergy Liquid Gels (cetirizine hydrochloride capsules, 10 mg): Store at temperatures between 15°-30°C. Avoid high humidity and excessive heat (above 40°C). Protect from light.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.